Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia
Fukuoka atherosclerosis trial (FAST)
Yasunori Sawayama, MD, PhD*,
Chie Shimizu, MD*,
Naoyasu Maeda, MD*,
Masafumi Tatsukawa, MD*,
Naoko Kinukawa, MS
,
Samon Koyanagi, MD, PhD
,
Seizaburo Kashiwagi, MD, PhD
and
Jun Hayashi, MD, PhD*,*
* General Medicinel, Fukuoka, Japan
Medical Informatics, Kyushu University Hospital, Fukuoka, Japan,
National Kyushu Medical Center, Fukuoka, Japan

View larger version (21K):
[in a new window]
|
Figure 1 Serum lipid levels in the probucol (triangles), pravastatin (squares) and control (circles) groups. Data are presented as the mean value ± SD. *p < 0.05; ***p < 0.001 vs. baseline.
|
|

View larger version (15K):
[in a new window]
|
Figure 2 Changes in intima-media thickness (IMT) in the probucol (triangles), pravastatin (squares) and control (circles) groups. Data are presented as the mean value ± SD. *p < 0.05; **p < 0.01 vs. baseline.
|
|

View larger version (11K):
[in a new window]
|
Figure 3 Kaplan-Meier estimates of the occurrence of all coronary events. Bold solid line = control group; thin solid line = pravastatin group; broken line = probucol group. There was a significant difference between the control group and probucol groups (*p < 0.05 by the log-rank test).
|
|
Copyright © 2002 by the American College of Cardiology Foundation.